Paul Mahon
General Counsel bei UNITED THERAPEUTICS CORPORATION
Vermögen: 8 Mio $ am 31.03.2024
Profil
Paul A.
Mahon is currently the Co-Managing Director at Unither Therapeutik GmbH.
He is also currently serving as the Secretary, Executive VP & General Counsel at United Therapeutics Corp.
and Miromatrix Medical, Inc. In the past, he worked as a Director at SteadyMed Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.04.2024 | 36 710 ( 0,08% ) | 8 Mio $ | 31.03.2024 |
Aktive Positionen von Paul Mahon
| Unternehmen | Position | Beginn |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | General Counsel | 01.01.2001 |
| MIROMATRIX MEDICAL INC. | General Counsel | 11.12.2023 |
Unither Therapeutik GmbH
 Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Paul Mahon
| Unternehmen | Position | Ende |
|---|---|---|
| STEADYMED LTD | Director/Board Member | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| MIROMATRIX MEDICAL INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Health Technology |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
